Tempus raises $110M series E

Tempus Labs Inc. (Chicago, Ill.) raised $110 million on Aug. 29 in a series E round led by new investor Baillie Gifford and funds managed by T. Rowe Price. Existing investors Revolution Growth, New Enterprise Associates and other undisclosed existing investors also participated.

Tempus has developed a machine learning platform designed to help physicians improve treatment decisions by comparing a cancer patient’s genetic and clinical profile to those of thousands of other patients with known treatment outcomes (see “Computing Care”)...